Bioclin SA
0.5 FTEBioclin reported total assets of 623,434 € at the end of the 2025 financial year (annual accounts filed with the NBB on 19 Jun 2026), with 0.5 full-time equivalent.
The score of Bioclin shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +86 % Total assets -10 % Headcount (avg FTE) -17 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Bioclin's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 8,400 € | ||||
| Equity | 274,684 € | ||||
| Cash | 39,539 € | ||||
| EBITDA | 51,545 € | ||||
| Total assets | 623,434 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 19 Jun 2026
- Year ended 31 Dec 2024filed on 30 Jun 2025
- Year ended 31 Dec 2023filed on 18 Jul 2024
- Year ended 31 Dec 2022filed on 19 Jul 2023
- Year ended 31 Dec 2021filed on 24 Jun 2022
Bioclin's financial analysis
- Solvency44.1%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Bioclin
Bioclin's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0416.553.335
- VAT number
- BE0416553335
- Peppol
- Registered · 0208:0416553335 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 30 Oct 1976
- Registered office
- 8400 Ostend
- Size
- Micro · 0.5 FTE
- Latest accounts
- 2025 · filed on 19 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Bioclin (SA) has been based in Ostend since 1976, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 8,400 € and equity of 274,684 €; its revenue is not published. With 0.5 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 44.1%, below the median of its sector (44.2%).
Companies similar to Bioclin
Companies in the same business, of comparable size and area, outside its group.
- Hubert Pellegrin Retail sale of pharmaceutical products Uccle · balance sheet 623,769 €
- Pharmacie Pirenne Retail sale of pharmaceutical products Soumagne · balance sheet 622,922 €
- Zichem Pharma Retail sale of pharmaceutical products Scherpenheuvel-Zichem · balance sheet 622,406 €
- Apotheek Queens Retail sale of pharmaceutical products Turnhout · balance sheet 621,995 €
- MVA Pharma Retail sale of pharmaceutical products Charleroi · balance sheet 621,644 €
- Heldo Retail sale of pharmaceutical products Erpe-Mere · balance sheet 621,357 €
- Pharmadil Retail sale of pharmaceutical products Dilbeek · balance sheet 620,651 €
- Pharmovan Retail sale of pharmaceutical products Leuven · balance sheet 626,313 €
Frequently asked questions about Bioclin
What is the revenue of Bioclin?
Bioclin files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Bioclin?
In Belgium, the VAT number is the company number prefixed with BE: BE0416553335 for Bioclin, if the company is VAT-registered. Its company number (CBE) is 0416.553.335.
Where is the registered office of Bioclin?
According to the CBE register, the registered office of Bioclin is in 8400 Ostend.
What is the equity of Bioclin?
At the close of the 2025 financial year, the equity of Bioclin amounts to 274,684 €, a solvency of 44.1% of total assets.
How many people work at Bioclin?
0.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Bioclin?
The register lists 6 active mandates at Bioclin. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Bioclin
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →